by Michael Fenimore | Mar 22, 2022 | Uncategorized
The current treatment of advanced, recurrent, and metastatic cervical cancer is difficult, especially as treatment progresses to the second line. Considerations for treatment are nuanced and numerous. Factors include prior treatments, treatment timing, and patient...
by Michael Fenimore | Mar 22, 2022 | Uncategorized
This COPE-certified small group educational experience is designed for optometrists involved in the management of patients with geographic atrophy (GA). Key goals of the curriculum are: ~ Discuss the prevalence of age-related macular degeneration ~ Articulate the...
by Michael Fenimore | Jan 28, 2022 | Uncategorized
Assessment and treatment of pain are challenges for healthcare providers and health systems. Treatment with opioid medications can decrease pain functionality but also may result in opioid tolerance, dependence, misuse, and overdose. It is important that opioids be...
by Michael Fenimore | Jan 26, 2022 | Uncategorized
Acute myeloid leukemia (AML) continues to be the most common acute leukemia in adults, with an incidence of 5.5 cases per 100,000 persons annually. As such, more education is needed on key topics including use of induction therapy in the non-elderly population,...
by Michael Fenimore | Jan 21, 2022 | Uncategorized
This interactive program discusses foundational knowledge on chronic rhinosinusitis with nasal polyps (CRSwNP) with respect to patient quality of life, disease progress, and underlying immunologic processes. In addition, it reviews the efficacy and safety of standard...
